Net profit of RPG Life Sciences rose 23.20% to Rs 1.54 crore in the quarter ended March 2019 as against Rs 1.25 crore during the previous quarter ended March 2018. Sales declined 17.57% to Rs 68.80 crore in the quarter ended March 2019 as against Rs 83.46 crore during the previous quarter ended March 2018.

For the full year,net profit declined 19.63% to Rs 10.81 crore in the year ended March 2019 as against Rs 13.45 crore during the previous year ended March 2018. Sales declined 4.01% to Rs 330.16 crore in the year ended March 2019 as against Rs 343.95 crore during the previous year ended March 2018.

Powered by Capital Market - Live News

RPG Life Sciences announced that the Board of Directors of the Company at its meeting held on 29 April 2019, has recommended a Final dividend of Rs.2.4 per share (i.e.30%), subject to the approval of the shareholders.

Powered by Capital Market - Live News

RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 29 April 2019.

Powered by Capital Market - Live News

Net profit of RPG Life Sciences declined 3.30% to Rs 5.28 crore in the quarter ended December 2018 as against Rs 5.46 crore during the previous quarter ended December 2017. Sales declined 4.90% to Rs 90.97 crore in the quarter ended December 2018 as against Rs 95.66 crore during the previous quarter ended December 2017.

Powered by Capital Market - Live News